The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
- Author:
Yu Bin SEO
1
;
Su-Jin MOON
;
Chan Hong JEON
;
Joon Young SONG
;
Yoon-Kyoung SUNG
;
Su Jin JEONG
;
Ki Tae KWON
;
Eu Suk KIM
;
Jae-Hoon KIM
;
Hyoun-Ah KIM
;
Dong-Jin PARK
;
Sung-Hoon PARK
;
Jin Kyun PARK
;
Joong Kyong AHN
;
Ji Seon OH
;
Jae Won YUN
;
Joo-Hyun LEE
;
Hee Young LEE
;
Min Joo CHOI
;
Won Suk CHOI
;
Young Hwa CHOI
;
Jung-Hyun CHOI
;
Jung Yeon HEO
;
Hee Jin CHEONG
;
Shin-Seok LEE
Author Information
- Publication Type:Special Article
- From:Infection and Chemotherapy 2020;52(2):252-280
- CountryRepublic of Korea
- Abstract: To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and theKorean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measlesmumps- rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults.
